Investigational Site Number : 2760004

Heidelberg 69120

0 studies enrolling now · 2 studies all time

What they study most

Metastatic Neoplasm, Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus

Studies at this site

• A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors — Stopped early
• Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine — Completed